Clinical Trial Update: PWS Outcomes Assessment Study

View source ↗

Summary

The Prader-Willi Syndrome outcomes assessment study (NCT04102839) sponsored by Soleno Therapeutics has completed. The update notes the trial status as COMPLETED…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prader-willi Syndrome

Drugs mentioned

• diazoxide choline (diazoxide choline)

Snippet

Sponsor: Soleno Therapeutics, Inc. | Conditions: Prader-Willi Syndrome | Status: COMPLETED